{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:48:48Z","timestamp":1788922128477,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The study was sponsored by Jiangsu Huatai Chenguang Pharmaceutical Co. Ltd,"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13318-025-00965-0","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:45:13Z","timestamp":1760003113000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study Evaluating the Pharmacokinetics of Single-Dose Tapentadol Hydrochloride Intravenous Infusion and Tapentadol Hydrochloride Oral Tablets in Patients with Pain"],"prefix":"10.1007","volume":"50","author":[{"given":"Zhiqin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaole","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yindong","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlian","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3547-5829","authenticated-orcid":false,"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"965_CR1","doi-asserted-by":"publisher","first-page":"215013192412535","DOI":"10.1177\/21501319241253547","volume":"15","author":"JG Katzman","year":"2024","unstructured":"Katzman JG, Gallagher RM. Pain: the silent public health epidemic. J Prim Care Community Health. 2024;15:21501319241253548.","journal-title":"J Prim Care Community Health"},{"issue":"9","key":"965_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, et\u00a0al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976\u201382.","journal-title":"Pain"},{"key":"965_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cnc.2017.08.002","volume":"29","author":"PM Orr","year":"2017","unstructured":"Orr PM, Bettina CS, Amy CB. The role of pain classification systems in pain management. Crit Care Nurs Clin N Am. 2017;29:407\u201318.","journal-title":"Crit Care Nurs Clin N Am"},{"issue":"10180","key":"965_CR4","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","volume":"393","author":"P Glare","year":"2019","unstructured":"Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019;393(10180):1537\u201346.","journal-title":"Lancet"},{"key":"965_CR5","unstructured":"Milani DAQ, Davis DD. Pain management medications. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560692\/."},{"key":"965_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0091270010394852","volume":"52","author":"P Dharmshaktu","year":"2012","unstructured":"Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012;52:6\u201317.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"965_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00484-9","volume":"9","author":"J Rosner","year":"2023","unstructured":"Rosner J, Andrade DCD, Davis KD, et\u00a0al. Central neuropathic pain. Nat Rev Dis Primers. 2023;9(1): 73.","journal-title":"Nat Rev Dis Primers"},{"key":"965_CR8","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2147\/IJGM.S419239","volume":"16","author":"NM Alorfi","year":"2023","unstructured":"Alorfi NM. Pharmacological methods of pain management: narrative review of medication used. Int J Gen Med. 2023;16:3247\u201356.","journal-title":"Int J Gen Med"},{"key":"965_CR9","unstructured":"US Department of Health and Human Services. Pain Management Best Practices Inter-Agency Task Force report: updates, gaps, inconsistencies, and recommendations. 2019. https:\/\/www.hhs.gov\/ash\/advisory-committees\/pain\/reports\/index.html. Accessed 8 May 2020."},{"issue":"5","key":"965_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/11536540-000000000-00000","volume":"27","author":"H Smith","year":"2010","unstructured":"Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2010;27(5):417\u201333.","journal-title":"Drugs Aging"},{"issue":"3","key":"965_CR11","first-page":"63","volume":"75","author":"BC Stephan","year":"2016","unstructured":"Stephan BC, Parsa FD. Avoiding opioids and their harmful side effects in the postoperative patient: exogenous opioids, endogenous endorphins, wellness, mood, and their relation to postoperative pain. Hawaii J Med Public Health. 2016;75(3):63\u20137.","journal-title":"Hawaii J Med Public Health"},{"issue":"5","key":"965_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/ACO.0b013e32835743b7","volume":"25","author":"A Steyaert","year":"2012","unstructured":"Steyaert A, Kock MD. Chronic postsurgical pain. Curr Opin Anaesthesiol. 2012;25(5):584\u20138.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"8","key":"965_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ejpain.2010.06.017","volume":"14","author":"HG Kress","year":"2010","unstructured":"Kress HG. Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon? Eur J Pain. 2010;14(8):781\u20133.","journal-title":"Eur J Pain"},{"issue":"1","key":"965_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1124\/jpet.107.126052","volume":"323","author":"TM Tzschentke","year":"2007","unstructured":"Tzschentke TM, Christoph T, K\u00f6gel B, et\u00a0al. (\u2212)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther. 2007;323(1):265\u201376.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"965_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/jpet.110.175042","volume":"337","author":"W Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der W, Tzschentke TM, Terlinden R, et\u00a0al. Synergistic interaction between the two mechanisms of action of tapentadol in analgesia. J Pharmacol Exp Ther. 2011;337(1):312\u201320.","journal-title":"J Pharmacol Exp Ther"},{"key":"965_CR16","unstructured":"Collegium Pharmaceutical, Inc. NUCYNTA\u00ae ER (tapentadol) extended-release tablets, for oral use, CII [package insert]. Stoughton, MA: Collegium Pharmaceutical, Inc.; 2023. Revised December 2023."},{"key":"965_CR17","unstructured":"Collegium Pharmaceutical, Inc. NUCYNTA\u00ae (tapentadol) tablets, for oral use, CII [package insert]. Stoughton, MA: Collegium Pharmaceutical, Inc.; 2023. Revised December 2023."},{"issue":"10","key":"965_CR18","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1185\/03007995.2011.611494","volume":"27","author":"R Riemsma","year":"2011","unstructured":"Riemsma R, Forbes C, Harker J, et\u00a0al. Systematic review of tapentadol in chronic severe pain. Curr Med Res Opin. 2011;27(10):1907\u201330.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"965_CR19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41598-017-02209-x","volume":"7","author":"Z Meng","year":"2017","unstructured":"Meng Z, Yu J, Acuff M, et\u00a0al. Tolerability of opioid analgesia for chronic pain: a network meta-analysis. Sci Rep. 2017;7(1):1995.","journal-title":"Sci Rep"},{"issue":"6","key":"965_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5055\/jom.2012.0139","volume":"8","author":"RC Dart","year":"2012","unstructured":"Dart RC, Cicero TJ, Surratt HL, Rosenblum A, Bartelson BB, Adams EH. Assessment of the abuse of tapentadol immediate release: the first 24\u00a0months. J Opioid Manag. 2012;8(6):395\u2013402.","journal-title":"J Opioid Manag"},{"issue":"8","key":"965_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/pm\/pnv032","volume":"17","author":"RC Dart","year":"2016","unstructured":"Dart RC, Surratt HL, Le Lait M-C, et\u00a0al. Diversion and illicit sale of extended release tapentadol in the United States. Pain Med. 2016;17(8):1490\u20136.","journal-title":"Pain Med"},{"issue":"1","key":"965_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/clpt.2008.80","volume":"84","author":"SE Kern","year":"2008","unstructured":"Kern SE, Stanski DR. Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug development. Clin Pharmacol Ther. 2008;84(1):153\u20137.","journal-title":"Clin Pharmacol Ther"},{"key":"965_CR23","unstructured":"Schug SA, Palmer GM, Scott DA, Alcock M, Halliwell R, Mott JF. Acute Pain Management: Scientific Evidence. 5th ed. Melbourne: Australian and New Zealand College of Anaesthetists; 2020:298\u2013301."},{"issue":"1","key":"965_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","volume":"113","author":"RH Dworkin","year":"2005","unstructured":"Dworkin RH, Turk DC, Farrar JT, et\u00a0al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1):9\u201319.","journal-title":"Pain"},{"key":"965_CR25","unstructured":"Price G, Patel DA. Drug bioavailability. 2023 Jul 30. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2025."},{"issue":"3","key":"965_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tvjl.2012.05.019","volume":"194","author":"M Giorgi","year":"2012","unstructured":"Giorgi M, Meizler A, Mills PC. Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs. Vet J. 2012;194(3):309\u201313.","journal-title":"Vet J"},{"issue":"4","key":"965_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5414\/CP201722","volume":"51","author":"K G\u00f6hler","year":"2013","unstructured":"G\u00f6hler K, Brett M, Smit JW, Rengelshausen J, Terlinden R. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations. Int J Clin Pharmacol Ther. 2013;51(4):338\u201348.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"965_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1556-4029.2012.02299.x","volume":"58","author":"W Kemp","year":"2013","unstructured":"Kemp W, Schlueter S, Smalley E. Death due to apparent intravenous injection of tapentadol. J Forensic Sci. 2013;58(1):288\u201391.","journal-title":"J Forensic Sci"},{"issue":"12","key":"965_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-257721","volume":"16","author":"VCR Avula","year":"2023","unstructured":"Avula VCR, Vullanki SS, Munivenkatappa S. Tapentadol dependence through intravenous injection (\u2018shooting\u2019) of crushed tablets associated with cutaneous pseudoallergic reactions. BMJ Case Rep. 2023;16(12): e257721.","journal-title":"BMJ Case Rep"},{"key":"965_CR30","doi-asserted-by":"crossref","unstructured":"Terlinden R, Ossig J, Fliegert F, Gohler K. Pharmacokinetics, excretion, and metabolism of tapentadol HCl, a novel centrally acting analgesic.in healthy subjects. J Pain. 2006;7(suppl 1):S26, Abstract 689.","DOI":"10.1016\/j.jpain.2006.01.091"},{"issue":"3","key":"965_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.tvjl.2013.09.011","volume":"198","author":"HK Lee","year":"2013","unstructured":"Lee HK, Lebkowska-Wieruszewska B, Kim TW, Kowaski CJ, Giorgi M. Pharmacokinetics of the novel atypical opioid tapentadol after intravenous, intramuscular and subcutaneous administration in cats. Vet J. 2013;198(3):620\u20134.","journal-title":"Vet J"},{"key":"965_CR32","first-page":"141","volume":"68","author":"M Giorgi","year":"2013","unstructured":"Giorgi M, Mills PC, Tayari H, Rota S, Breghi G, Briganti A. Plasma concentrations of tapentadol and clinical evaluations of a combination of tapentadol plus sevoflurane for surgical anaesthesia and analgesia in rabbits (Oryctolagus cuniculus) undergoing orchiectomy. Isr J Vet Med. 2013;68:141\u20138.","journal-title":"Isr J Vet Med"},{"issue":"5","key":"965_CR33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jvp.12123","volume":"37","author":"E Lavy","year":"2014","unstructured":"Lavy E, Lee HK, Mabjeesh SJ, Sabastian C, Baker Y, Giorgi M. Use of the novel atypical opioid tapentadol in goats (Capra hircus): pharmacokinetics after intravenous, and intramuscular administration. J Vet Pharmacol Ther. 2014;37(5):518\u201321.","journal-title":"J Vet Pharmacol Ther"},{"issue":"10","key":"965_CR34","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1517\/14656566.2012.696097","volume":"13","author":"RB Raffa","year":"2012","unstructured":"Raffa RB, Buschmann H, Christoph T, et\u00a0al. Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother. 2012;13(10):1437\u201349.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"965_CR35","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/jat\/34.8.450","volume":"34","author":"JA Bourland","year":"2010","unstructured":"Bourland JA, Collins AA, Chester SA, Ramachandran S, Backer RC. Determination of tapentadol (Nucynta\u00ae) and N-desmethyltapentadol in authentic urine specimens by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2010;34(8):450\u20137.","journal-title":"J Anal Toxicol"},{"issue":"5","key":"965_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/11589080-000000000-00000","volume":"25","author":"CT Hartrick","year":"2011","unstructured":"Hartrick CT, Rozek RJ. Tapentadol in pain management: a \u03bc-opioid receptor agonist and noradrenaline reuptake inhibitor. CNS Drugs. 2011;25(5):359\u201370.","journal-title":"CNS Drugs"},{"issue":"3","key":"965_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF03190478","volume":"32","author":"R Terlinden","year":"2007","unstructured":"Terlinden R, Ossig J, Fliegert F, Lange C, Gohler K. Absorption, metabolism, and excretion of 14C-labeled tapentadol HCL in healthy male subjects. Eur J Drug Metab Pharmacokinet. 2007;32(3):163\u20139.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"965_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1358\/mf.2010.32.1.1434165","volume":"32","author":"R Terlinden","year":"2010","unstructured":"Terlinden R, Kogel BY, Englberger W, Tzschentke TM. In vitro and in vivo characterization of tapentadol metabolites. Methods Find Exp Clin Pharmacol. 2010;32:31\u20138.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"3","key":"965_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/1658-354X.115319","volume":"7","author":"DR Singh","year":"2013","unstructured":"Singh DR, Nag K, Shetti AN, Krishnaveni N. Tapentadol hydrochloride: a novel analgesic. Saudi J Anaesth. 2013;7(3):322\u20136.","journal-title":"Saudi J Anaesth"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-025-00965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-025-00965-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-025-00965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:03:59Z","timestamp":1761127439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-025-00965-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1007\/s13318-025-00965-0","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was sponsored by Jiangsu Huatai Chenguang Pharmaceutical Co. Ltd, (Taizhou Jiangsu, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Xiaoqiang Li and Na Zhou are employees of Jiangsu Hengrui Pharmaceuticals Co., Ltd, (Taizhou Jiangsu, China). The other authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The data supporting the findings of this study are included within the manuscript, figures, and tables. Additional data that can be reasonably shared without compromising participants\u2019 protected health information can be accessed by contacting the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The study protocol and any amendments were approved by the Ethics Committee of the Fifth Affiliated Hospital of Guangzhou Medical University (ethics approval no. GYWY-Y2021-66, date: 25 November 2021). The study was carried out in accordance with the principles of the Declaration of Helsinki, the good clinical practice guidelines of the International Conference on Harmonization, and local laws and regulations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants were provided with a written informed consent document before enrollment.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to the study\u2019s conception and design. Material preparation, data collection, and analysis were performed by Zhiqin Hu, Tenghua Wang, Ying Luo, Xiaole Wang, Chen Li, Zhixin Zhang, Xuan Wang, Yaoxuan Zhan, Xintong Liang, Yindong Zong, Lizhong Liu, Jinlian Bi, Yongdong Zhang, and Haiyan Liu. .  Zhiqin Hu and Yi Fang wrote the paper with input from all authors.\u00a0All authors commented on previous versions of the manuscript and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}